UGT1A7

Chr 2

UDP glucuronosyltransferase family 1 member A7

Also known as: UDPGT 1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G

This gene encodes UDP-glucuronosyltransferase 1A7, an enzyme that conjugates lipophilic substrates with glucuronic acid to facilitate their excretion, playing a critical role in drug metabolism and detoxification of endogenous compounds including hormones and xenobiotics. The gene is tolerant to loss-of-function variants (LOEUF 1.463), and while mutations in related UGT1A genes cause Gilbert syndrome and Crigler-Najjar syndrome with autosomal recessive inheritance, specific disease associations for UGT1A7 mutations are not well-established in the pediatric population. UGT1A7 is part of a complex locus encoding multiple UDP-glucuronosyltransferases that primarily affects drug metabolism and detoxification pathways.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
11
Pubs (1 yr)
52
P/LP submissions
22%
P/LP missense
1.46
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryUGT1A7
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
41 unique Pathogenic / Likely Pathogenic· 344 VUS of 494 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.46LOEUF
pLI 0.000
Z-score -0.03
OE 1.01 (0.711.46)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.41Z-score
OE missense 1.07 (0.971.17)
314 obs / 294.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.01 (0.711.46)
00.351.4
Missense OE1.07 (0.971.17)
00.61.4
Synonymous OE1.30
01.21.6
LoF obs/exp: 20 / 19.8Missense obs/exp: 314 / 294.1Syn Z: -2.56
DN
0.75top 25%
GOF
0.72top 25%
LOF
0.2190th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

494 submitted variants in ClinVar

Classification Summary

Pathogenic23
Likely Pathogenic18
VUS344
Likely Benign80
Benign9
Conflicting18
23
Pathogenic
18
Likely Pathogenic
344
VUS
80
Likely Benign
9
Benign
18
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
8
1
14
0
23
Likely Pathogenic
8
8
2
0
18
VUS
3
314
23
4
344
Likely Benign
1
26
11
42
80
Benign
0
3
3
3
9
Conflicting
18
Total203525349492

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

UGT1A7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →